Removing bladder tumors with a new retrieval device
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a special device that may help doctors remove bladder tumors in one piece during surgery. The device is used along with the standard surgery to see if it removes the whole tumor more easily and safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a bladder tumor that is not growing into the muscle layer of the bladder.
- The largest tumor must be 5 cm (about 2 inches) or less.
- You must have an upcoming surgery to remove the bladder tumor (called a transurethral resection).
- You have not had bladder tumor surgery within the last 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
This trial is testing a new way to perform surgery for people with newly diagnosed non-muscle-invasive bladder cancer. The goal is to see if a special technique during the tumor removal procedure can help reduce the chance of the cancer coming back.
This trial tests a new robotic system to remove bladder tumors in one piece (en-bloc resection) for people with early-stage, non-muscle invasive bladder cancer. It may offer a more precise surgical option for eligible patients.
This study looks at whether removing nearby lymph nodes during radical cystectomy (bladder removal) improves outcomes for people with high-risk non–muscle-invasive bladder cancer. It may help doctors choose the best surgical approach to reduce the chance of cancer coming back.
This trial tests whether using a patient's own tumor cells in lab-made clusters (PTCs) can help guide chemotherapy before bladder removal surgery for muscle-invasive bladder cancer. If you qualify, you'll receive personalized treatment followed by surgery.
This trial is testing whether artificial intelligence (AI) can help surgeons perform a more precise removal of bladder tumors during a procedure called TURBT. It is for people with early-stage bladder cancer that hasn't spread into the muscle layer.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.